Home
About
Publications Trends
Recent Publications
Expert Search
Archive
novel compounds
How are Novel Compounds Discovered?
The discovery of novel compounds often begins with high-throughput screening of large chemical libraries. Researchers use advanced techniques like
computer-aided drug design
,
structure-based drug discovery
, and
natural product isolation
to identify promising candidates. Once identified, these compounds undergo rigorous
preclinical testing
to evaluate their efficacy and safety.
Frequently asked queries:
What are Novel Compounds?
How are Novel Compounds Discovered?
What are Some Examples of Novel Compounds in Cancer Research?
What Challenges Do Novel Compounds Face?
How Do Novel Compounds Enhance Existing Treatments?
What is the Future of Novel Compounds in Cancer Treatment?
What are the major achievements of EORTC?
Can Keratins be Targeted for Cancer Therapy?
How Can We Address These Disparities?
What Do Major Health Organizations Say?
What are the Limitations of PDX Models?
What is the Role of Psychological Support?
How do comorbidities influence cancer prognosis?
What are Altered Target Sites?
Does Diet Play a Role in Cancer Prevention?
Are There Any Promising Alternatives on the Horizon?
What is the role of accelerated approval pathways?
What Precautions Should Be Taken When Using Cotton Swabs?
What Should Patients Look for in a Yoga Instructor?
What is the Impact of Psychological and Social Support?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe